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Background: An in-vitro setup was established in order to determine a) the diffusion activities of eight otic
preparations (AurizonW, Eas OticW, Epi OticW, OtifreeW, OtomaxW, PanologW, PosatexW, SurolanW) through synthetic
cerumen, and b) the ceruminolytic capacity and impregnation effects of these products. The main lipid classes of
canine cerumen produced with moderate, non-purulent otitis externa were determined by thin layer
chromatography and were subsequently used to produce a standardised synthetic cerumen (SCC). SCC was filled
into capillary tubes, all of which were loaded with six commercially available multipurpose otic medications and
two ear cleaners, each mixed with two markers in two experimental setups. These two marker compounds (Oil red
O and marbofloxacin) were chosen, since they exhibit different physicochemical drug characteristics by which it is
possible to determine and verify the diffusion activity of different types of liquids (i.e. the otic preparations). A
synthetic cerumen described in the literature (JSL) was also used for comparison as its lipid composition was
different to SCC. The diffusion activities of the otic preparations through both types of synthetic cerumen were
studied over 24 hours. A second in-vitro experiment determined both the ceruminolytic activity and impregnation
effect of the otic preparations by comparing the weight loss or weight gain after repeated incubation of JSL.
Results: Canine cerumen is mainly composed of triglycerides, sterol esters, fatty acid esters and squalene. The
diffusion experiments showed a high diffusion efficacy along with a high impregnation effect for one test product.
All the other products exhibited a lower diffusion activity with a mild to moderate impregnation effect. A mild
ceruminolytic activity was observed for the two ear cleaners but not for any of the otic medications.
Conclusions: The present study demonstrates that there are significant differences in the diffusion characteristics
and ceruminolytic properties of the eight tested otic preparations.
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Canine otitis externa (OE) is one of the most common
diseases in small animal practice [1,2]. It is a syndrome
with a multifactorial aetiology. The factors are classified as
predisposing (increase the risk of otitis), primary (directly
induce otitis), secondary (contribute to otitis only in an
abnormal ear or in conjunction with predisposing factors),* Correspondence: jessica.stahl@tiho-hannover.de
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reproduction in any medium, provided the orand perpetuating (result from inflammation and pathology
in the ear, prevent resolution of otitis) [3-6].
In the external ear canal, cerumen influences the
effective barrier function for the underlying cutaneous
epithelium. The presence of cerumen is normal and is
mandatory for a physiological movement of microorganisms
or foreign substances from the deep ear canal towards its
external opening [7,8]. Cerumen is a complex mixture of
desquamated keratinocytes and debris in combination
with secretions of both the ceruminous and the sebaceous
glands of the external ear canal [9,10]. Although gland
density and distribution differs markedly between canine
individuals, a general pattern has been observed with
sebaceous tissue increasing gradually from the proximald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Lipid composition of canine cerumen of 12 healthy
dogs and 12 dogs with acute moderate, non-purulent OE
Lipid % of Total lipids





Alkanes n.q. n.q. n.q. n.q.
Cholesterol 1.68 0.66 1.55 1.28
Cholesteryl sulphate 0.12 0.13 0.08 0.13
Ceramide [AP] 0.78 0.38 0.71 0.75
Ceramide [AP/AS] 0.48 0.23 0.35 0.35
Ceramide [AS] 0.31 0.22 0.25 0.27
Ceramide [EOS] n.d. n.d. n.d. n.d.
Ceramide [NP] 0.45 0.22 0.48 0.34
Ceramide [NS] 0.33 0.27 0.66 0.56
Fatty acid ester 8.50 3.36 5.79 4.47
Free fatty acids 1.50 0.62 1.42 1.21
Galactocerebrosides 0.31 0.34 0.23 0.50
Phospholipids 0.08 0.12 0.29 0.60
Squalene 2.08 2.41 3.19 2.58
Sterol ester* 14.30 10.24 6.97 5.07
Triglycerides 21.01 6.08 18.89 13.99
The quantities are expressed as means and standard deviations after
determination with thin layer chromatography, n.d. = not detectable, n.q. = not
quantifiable; asterisks indicate p < 0.05 (t-test with Mann Whitney test, two-tailed).
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number of ceruminous glands decrease [11].
In chronic OE, the quantity of ceruminous glands
increases significantly, caused by the inflammatory process
[12] and gland hyperplasia can be observed. Another study
[11] found no relevant differences between inflamed and
healthy ears with regard to the gland distribution and hair
follicle density despite the fact that the glands and hair
follicles became hyperplastic in affected ears. However,
the lipid content of cerumen from inflamed ears is
significantly lower than from healthy ears [7]. Regarding
the lipid composition of human cerumen, several studies
have demonstrated high amounts of cholesterol, sterol
ester and fatty acids [9,10,13], but there is a lack of
information about canine cerumen lipids except for fatty
acids which are found regularly and in high quantities in
OE-affected ears [14].
Topical therapy is an important part of the treatment of
inflamed ears. Multipurpose products (otic preparations)
exhibiting antibacterial, antifungal or anti-inflammatory
properties are frequently indicated, particularly initially,
because of the mix of microorganisms, inflammation and
sometimes, parasites that are present at the time of
diagnosis [1,3]. According to the package leaflets of such
otic preparations, the topical treatment should be
performed after mechanical (not supported by many
specialists) or chemical removal of cerumen from the
external ear canal [15,16]. However, cerumen may remain
in the external ear canal and can reduce treatment
effectivity. Otic preparations with active ingredients
against OE should remain inside the external ear canal for
an adequate amount of time in order to provide adequate
antibacterial, antifungal and anti-inflammatory effects.
Furthermore, ceruminolytic activity and diffusion through
cerumen residues are beneficial for high efficacy on the
skin surface.
The objective of the present study was to determine the
diffusion activity of eight commercial otic preparations
through cerumen. Therefore, an in-vitro method was
developed using synthetic canine cerumen where diffusion
activities could be measured by applying two marker
compounds with different physicochemical characteristics.
In addition, the impregnation effect and ceruminolytic
activity of the test products were studied in the in-vitro
setup.
Results
The lipid analysis of canine cerumen revealed high levels
of squalene, fatty acid esters, sterol esters and triglycerides.
All other lipid classes were found with amounts smaller
than 2.5% of the total cerumen lipids (Table 1).
The extent and velocity of the diffusion activities in
SCC are shown in Figure 1. Oil red O added to the ear
cleaners Epi OticW and OtifreeW exhibited a slowerdiffusion activity (1.0 and 2.2 cm) compared to AurizonW
(5.1 cm) and the control (2.5 cm). SurolanW showed the
lowest diffusion (0.4 cm) of all the investigated otic
preparations (Figure 1). The diffusion through JSL showed
comparable results except for the control (Figure 2).
AurizonW diffused to the greatest degree (1.05 cm after
24 hours), followed by OtifreeW (0.54 cm). The control
diffused only 0.2 cm.
The determination of marbofloxacin in the SCC revealed
a positive correlation of marbofloxacin with the Oil red O
colour in case of AurizonW (5 cm diffusion lengths). No
marbofloxacin was determined at this position in any
of the capillary tubes filled with the other seven otic
preparations (Figure 3).
The examination of the ceruminolytic activity of the
test products showed that Eas OticW and OtifreeW were
able to remove some cerumen after incubation, though
with a high variability in the Eas OticW samples (Table 2,
Figures 4 and 5). All products except the ear-cleaning
solutions (OtifreeW, Epi OticW) and the control exhibited
a weight gain indicating an impregnation by either
incorporation or adhesion.
Discussion
Due to pathological changes in the ceruminous glands, the
total amount of lipids (% by weight) of canine cerumen of
Figure 2 Mean diffusion of Oilred O supplemented to eight otic
preparations through synthetic canine cerumen (JSL), n = 6,
asterisks (***) indicate p < 0.001 after 1440 h (AurizonW vs.
seven other preparations and control).
Figure 1 Diffusion of Oilred O supplemented to eight otic preparations through synthetic canine cerumen (SCC), means ± standard
deviations, n = 6, asterisks (***) indicate p < 0.001 after 1440 h (AurizonW vs. seven other formulations and control).
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healthy ears [7]. In our analysis, however, the detailed
analysis of various lipid classes in canine cerumen from
healthy and inflamed ears demonstrated comparable
lipid compositions except for sterol ester (Table 1). The
lipid composition of the SCC used in the present study
differed from that implemented by Sánchez-Leal et al.
[17]. However, these investigators used synthetic cerumen
based on the average results of human and canine
cerumen studies [9,10,14] with diminished concentrations
of oleic acid to obtain adequate consistency and malleability.
Thus, the main components in their synthetic cerumen
were fatty acids (myristic acid, palmitic acid and oleic
acid). In contrast, triglycerides dominated in our cerumen
composition derived from the cerumen of OE-affected
dogs. This difference may be due to variant methodologies
of extraction and analysis or the time of the year when the
sampling was done. Furthermore, it is known that storage
before analysis can promote lipase activity in cerumen
with the result that the triglycerides are metabolised to
fatty acids. In our study, the lipids were immediately
extracted, but information about storage times is not
available in the literature data on which the synthetic
cerumen (JSL) described by Sánchez-Leal et al. [17] was
based. To overcome this lack of information, the diffusion
studies were performed using both these lipid mixtures.
The results were found to be similar: in the case of
persistent cerumen films in the auditory canal, AurizonW
would exhibit the fastest diffusion through the cerumen
lipids.
The lipid classes present in the synthetic cerumen
resulted in a particular lipid architecture [18], which had
to be softened and dissolved to provide adequate space
for diffusion in our experiments. It seems that the
content of sorbitan oleate in AurizonW with a molecular
structure similar to several skin penetration enhancers
like sucrose oleate [19] plays a major role in this respect.
Nevertheless, it cannot be ruled out that the other excipients
used in AurizonW such as the medium-chain triglycerides,
silicon dioxide or propyl gallate interact with the cerumen
lipids and promote diffusion activity. Since all the otherotic preparations tested, except for the ear cleaners,
contain liquid paraffin, the lower diffusion activity of these
products may even be due to its supplementation. Liquid
paraffin is a mixture of various alkanes, which are only
marginally detectable in canine cerumen, which may be a
reason why liquid paraffin-containing products exhibit
low diffusion activities. In contrast, the composition of
AurizonW is more comparable to the composition of
canine cerumen with regard to its triglyceride content
and, therefore, it is not surprising that AurizonW showed a
better diffusion activity.
Penetration through lipid-rich domains in the skin is
mainly determined by the lipophilicity of a drug. In
addition, the melting point and the molecular weight
can influence the diffusion process [20]. Oil red O was
chosen in order to visualise the diffusion of a lipophilic
drug (LogP 7.6) with a moderate molecular weight of
409 g/mol and a melting point of 120°C. For comparison,
the diffusion of a hydrophilic drug (marbofloxacin) with
similar molecular weight (362 g/mol) and a melting
point of 268°C was selected. Marbofloxacin has com-
parable diffusion behaviour to Oil red O, although a main
physicochemical characteristic for diffusion through lipid
layers, its lipophilicity, differs markedly. The HPLC ana-
lysis ruled out that only lipophilic compounds like Oil red
O diffused through cerumen. From this result it can be
Figure 3 Oil red O diffusion through synthetic canine cerumen
(SCC) after 24 hours, 1 = control (SCC), 2 = AurizonW, 3 = Epi
OticW, 4 = Eas OticW, 5 = PanologW, 6 = PosatexW, 7 = OtomaxW,
8 = SurolanW, 9 = OtifreeW. The yellow box indicates the
approximate area of SCC sampling for the HPLC analysis of
supplemented marbofloxacin.
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drug characteristics similar to the marker compounds
used in the diffusion test would exhibit similar diffusion
behaviour.
The ceruminolysis results showed that the high viscosity
of some of the products led to a weight gain due to
impregnation (Tests 1–3). Since impregnation can be
caused either by incorporation of the product and
disintegration of cerumen lipids or by adhesion to the
cerumen surface, the products were removed from theTable 2 Percentage of standardised synthetic cerumen (JSL) r
Test product
Test 1 Test 2
Mean ± SD Mean ± SD
AurizonW −42.7 ± 14.4 −29.8 ± 4.2
Eas OticW −46.2 ± 2.9 −3.0 ± 8.7
Epi OticW −9.2 ± 3.1 −12.4 ± 3.2
OtifreeW −8.1 ± 4.3 −3.5 ± 2.7
OtomaxW −68.6 ± 6.7 −19.3 ± 10.0
PanologW −57.8 ± 10.4 −15.5 ± 5.8
PosatexW −58.2 ± 10.8 −32.4 ± 11.8
SurolanW −20.4 ± 8.6 −19.4 ± 7.5
Control (water) −2.5 ± 1.1 −3.4 ± 1.6
* Weighing was performed after washing with cold water (mean ± standard deviatio
Positive values indicate ceruminolysis; negative values indicate that there has beentubes in Test 4 thereby allowing the evaluation of the
ceruminolytic effects of the viscous products. AurizonW,
OtomaxW, PanologW and PosatexW exhibited a high
potency to impregnate the cerumen, while Eas OticW and
SurolanW showed an intermediate potency. The ear cleaners
Epi OticW and OtifreeW had very little impregnation
potency, as expected. These differences may be due to the
different amounts of viscous excipients like liquid paraffin
(Eas OticW, OtomaxW, PosatexW, SurolanW, PanologW) or
medium-chain triglycerides (AurizonW), all of which are
not included in the ear cleaners.
Since the investigated otic preparations (with the
exception of Epi OticW and OtifreeW) have to remain in
the external ear canal to exhibit optimal antimicrobial,
antifungal or antiparasitic activity, a high impregnation
potency will contribute to a good efficacy. With regard
to the results of the diffusion study, AurizonW seems to
provide ideal conditions for its active compound
marbofloxacin to get into the cerumen. On the other
hand, none of the products (except for Eas OticW with a
high standard deviation) performing a high or intermedi-
ate impregnation effect exhibited any ceruminolytic
activity. A slight weight loss was only found with
OtifreeW and Eas OticW. It can just be assumed that
propylene glycol (excipient in OtifreeW) caused disturbances
in the lipid architecture of the cerumen and elimination,
since propylene glycol has been described as being able to
modify skin penetration of topically applied drugs such as
tenoxicam or bupranolol [21-24].
Limitations
The penetration of the active components of the tested
products is based on the assumption that they have
similar physicochemical properties as Oil red O or
marbofloxacin. Both these compounds have comparable
molecular weights (362–409 g/mol) and melting pointsemoved after each run (Test)
Weight removed (%)
Test 3 Mean of
tests 1-3
Test 4*
Mean ± SD Mean ± SD
−29.3 ± 4.9 −34 −5.3 ± 3.8
−17.7 ± 14.7 −22.3 2.7 ± 6.5
−11.8 ± 2.5 −11.2 −7.1 ± 2.0
−10.3 ± 5.6 −7.3 5.6 ± 1.2
−22.7 ± 6.3 −36.9 −18.5 ± 3.0
−34.7 ± 8.4 −36 −5.4 ± 7.1
−47.4 ± 9.9 −46 −64.4 ± 5.5
−23.5 ± 8.8 −21.1 −3.7 ± 7.1
−2.6 ± 1.0 −2.8 −2.1 ± 3.3
n), n = 4 loadings per test.
impregnation of the product.
Figure 4 Mean percentage of standardised synthetic cerumen
(JSL) removed after Tests 1–3, n = 4 loadings; positive values
indicate ceruminolysis, negative values indicate that there has
been impregnation of the product.
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evaluated assuming that penetration is mainly influenced
by the lipophilicity of the drug (similar to skin permeability
through lipid-rich domains). Oil red O and marbofloxacin
are extremely different concerning their lipophilicity.
They were chosen to cover a wide range of different
lipophilicities. Nevertheless, the eight otic preparations also
contain active components with other physicochemicalFigure 5 Mean percentage of standardised synthetic cerumen
(JSL) removed after Test 4; weighing was performed after
washing with cold water in order to remove all product
residues, n = 4 loadings per Test. Positive values indicate
ceruminolysis; negative values indicate that there has been
impregnation of the product.qualities, which may not be covered by the present study.
Furthermore, missing components of natural cerumen like
proteins or keratinocytes may affect the penetration of
active components as well, due to their breaking up the
lipid matrix and unknown interactions with the active
components.
The ceruminolytic activity was evaluated on the basis
of the lipolytic effect of the products. The addition of
other components of natural cerumen like keratinocytes
or proteins would provide results closer to the in-vivo
situation, albeit possibly with increased test variability.
Due to the lack of information on these components of
natural cerumen, further studies are required.Conclusions
In conclusion, the present study is the first investigation
providing detailed information about the lipid composition
of canine cerumen from healthy and inflamed ears. The
results of the in-vitro assays demonstrate a high variability
of otic preparations with respect to their diffusion potency
through canine cerumen and their ceruminolytic effect. Of
the six multipurpose otic products tested, only AurizonW
exhibited a fast diffusion through synthetic cerumen and
an impregnation effect, though without any ceruminolytic
activity. A slight ceruminolytic effect was observed for one
test product, the aqueous ear cleaner OtifreeW; less
consistent results were found for the ear cleaner Epi OticW.Methods
Lipid analysis of canine cerumen
Canine cerumen was collected with lipid-free cotton
buds from dogs (n = 12) of different sexes, breeds and
ages, all of which had an acute, moderate OE. Purulent
OE ears were excluded from the study (gross examination
without cytology). Information about the aetiologies
was not available. The dogs were owned by the Clinic
for Small Animals, University of Veterinary Medicine
Hannover, Foundation, and had not been pretreated with
any otic preparations. Cerumen of clinically healthy dogs
(n = 12) of different sexes, breeds and ages, was collected
as well.
Lipid extraction was performed according to Reiter
et al. [25]. In brief, the ceruminal lipids of each dog
were extracted from the cotton bud with hexane/ethanol
(95/5; V/V) for 20 minutes by sonication. The supernatant
was collected and the procedure was repeated one more
time. After evaporation of the solvent, the total amount of
lipid was determined. The analysis of the different
lipid classes of each dog was performed by thin layer
chromatography (TLC, Figure 6). The extracted lipids
were dissolved in chloroform/methanol (2:1, v/v) and were
applied to TLC plates (Merck, Darmstadt, Germany) using
a previously described methodology [26]. Co-migrated
Figure 6 Thin layer chromatography presenting the composition
of canine cerumen in comparison to lipid standards.
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different lipid classes.Synthetic canine cerumen (SCC)
SCC was used in order to provide large amounts of
cerumen for the in-vitro studies without the effects of other
natural cerumen ingredients like keratinocytes and pro-
teins. According to authors’ knowledge, the composition of
canine cerumen components has not been fully described
as yet. Thus, high variability was avoided by using SCCbased on the essential lipid classes of canine cerumen, i.e.
components with >2.5% of the total lipids determined by
TLC analysis were used: 9.16% squalene, 16.62% fatty acid
ester, 19.98% sterol ester and 54.24% triglycerides (all from
Sigma-Aldrich, Steinheim, Germany).Diffusion activity
SCC (47–57 mm3) was filled into glass capillaries (diameter
1.15 ± 0.05 mm, length 75 ± 1 mm). The otic preparations
(Table 3) were added (16–21 mm3) onto the SCC in the
capillary tubes. Before starting the experiments, each
of the products was mixed with two markers (two
independent experiments with either Oil red O or
marbofloxacin supplementation, Table 4), which exhibit
different physicochemical drug characteristics that enable
the extent and velocity of product diffusion through the
SCC to be determined.
Marker 1: Oil red O (10 mg/ml) was used to visualise
the diffusion distance of each of the otic preparations by
measuring the diffusion pathway of Oil red O optically
after 24 hours with a ruler. Oil red O in SCC served as
the control. The capillaries were stored at 32°C in a
water bath to imitate the physiological conditions of the
external ear canal of the dog. An identical experiment
was performed with synthetic cerumen (JSL) as used by
Sánchez-Leal et al. [17], which had the composition:
33.6% myristic acid, 33.6% palmitic acid, 9.4% oleic
acid, 10.9% cholesterol and 12.5% squalene. Each otic
preparation was studied twice, i.e. in six glass capillaries
on SCC (n = 6) and on JSL (n = 6).
Marker 2: Marbofloxacin (10 mg/ml) was chosen as
the second marker, which is also an active compound of
one test product (AurizonW). A validated high performance
liquid chromatography method (HPLC) [27] was used
to detect the diffusion of the active ingredient
(marbofloxacin) through the SCC in comparison to
the dye Oil red O. For this purpose, marbofloxacin was
added to each test product before it was applied to the
SCC. After incubating for 24 hours, samples were taken
from the 5 cm diffusion distance for each test product
(Figure 3).
Extraction was performed by adding 300 μl NaOH
(5 N) and shaking for 10 minutes. After centrifugation at
230 g for 10 minutes, 200 μl supernatant was taken and
was mixed with 200 μl HCl (5 N) before analysis. A
Beckman HPLC instrument (Munich, Germany) with the
following parts was used: a 126 pump with a flow rate of
1.0 ml/min, a 507 autosampler with 100 μl injection
volume, a RF535 detector (Shimadzu, Kyoto, Japan) with
an excitation wavelength of 280 nm and a detection
wavelength of 450 nm, a CC 250/4 NUCLEODUR 100–5
C18ec column and a column heater (40 C; Spark Holland,
Emmen, The Netherlands).
Table 3 Otic preparations with their active ingredients, excipients and galenic formulation; the asterisks indicate the
ear cleaners








Propyl gallate (E310), sorbitan oleate,
silicon dioxide, medium-chain
triglycerides








Liquid paraffin suspension Virbac Tierarzneimittel GmbH,







Liquid paraffin, hydrocarbon gel suspension Intervet Deutschland GmbH,
Unterschleissheim, Germany,






Plastibase 10W (95% liquid paraffin,
5% polyethylene)
suspension Novartis Tiergesundheit GmbH,






Liquid paraffin, hydrocarbon gel
(5% polyethylene in 95% mineral oil),
lauric acid




W Prednisolone acetate, polymyxin
B sulphate, miconazol nitrate
Silicon dioxide, liquid paraffin suspension Janssen Animal Health, Neuss,
Germany, Batch number BHB1L02
Epi Otic
W*
Salicylic acid, dictyle sodium,
sulfosuccinate, chloroxylenol,
EDTA, monosaccharides
solution Virbac Tierarzneimittel GmbH,
Bad Oldesloe, Germany, Batch
number 3EP8
Otifree
W* Propylene glycol, cremophor,
calendula extract, basil oil, water
solution Vétoquinol GmbH, Ravensburg,
Germany, Batch number 0B4953K
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The ceruminolytic activity of each otic preparation was
studied by using JSL as outlined by Sánchez-Leal et al.
[17]. This was chosen because the texture of the SCC
based on the main lipid classes of canine cerumen was
too liquid. 250 mg JSL was filled in plastic tubes at 45°C
(the solid cerumen became liquid) and was cooled down
to 32°C.
The initial weight of the tubes with JSL was determined.
Subsequently, 1 ml of the test product was added. After
20 minutes incubation on a shaker (150 rpm, 32°C) to
simulate contact time and the head shaking occurring in a
real canine ear, the tubes were inverted for 1 hour in order
to provide enough time for the dispersed JSL and the test
product mixture to run out of the tube. Due to the high
viscosity (impregnation effect) of some of the products,
small amounts of the preparations were still attached to
the vial after it was inverted. The weight of the tubes
was determined (Test 1) again to calculate the exact
amount of remaining JSL (ceruminolysis) and attached
ear products (impregnation).Table 4 Physicochemical properties of Oil red O and
marbofloxacin
Oil red O Marbofloxacin
Molecular weight (g/mol) 409 362
LogP 7.577 −0.835
Melting point (°C) 120 268To gain comparable results to Sánchez-Leal et al.
[17] and to simulate consecutive applications of the
ear products, this procedure was repeated three times
(Tests 2–4). The weight of the tubes before each test
run was set as 100%. Due to the high viscosity of
some of the products, water was used to remove all
test preparations left in the tubes in the final test.
In the present study, the ceruminolytic activity was
defined as the weight loss of JSL after consecutive incu-
bation and rinsing of otic preparations (Tests 1–4).
Ceruminolysis causes disintegration and elimination of
cerumen and so will be characterised by weight loss.
Conversely, any increase in weight would indicate an
impregnation of the product in the JSL. Four loadings of
each otic preparation were run simultaneously. Water
was used as a negative control with low variability.Statistics
The differences in the quantities of the lipids between OE
cerumen and cerumen of healthy dogs were statistically
analysed by t-test followed by the Mann Whitney test
as post-hoc test. A level of significance of p < 0.05
was adopted.
The differences in the diffusion rates after 24 hours
and the percentages of ceruminolytic removal were
statistically analysed by One-Way Analysis of Variance
(ANOVA) with Tukey’s multiple comparison test as
post-hoc test. A level of significance of p < 0.05 was
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Software, Inc., La Jolla, USA) was used for the analyses.
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